Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that GLP-1 receptor agonists are linked to a 40% increased risk of non-scarring alopecia in adults, mainly due to weight loss-induced micronutrient deficiencies, with semaglutide and tirzepatide showing the highest hair loss signals.

This study found that GLP-1 receptor agonists are linked to a significant 40% increased risk of non-scarring alopecia, which may result from weight loss-induced micronutrient deficiency.

In this prospective observational study, researchers found that androgenetic alopecia was the most common hair disorder among patients at a South Indian tertiary care center, predominantly affecting males, while telogen effluvium showed significant improvement after 3 months, highlighting stress as a key modifiable risk factor.

This study found that switching patients with alopecia areata unresponsive to topical clobetasol 17 propionate 0.05% to anthralin treatment led to improved treatment success.

In this study, researchers explored the link between COVID-19 and hair loss, finding that the virus can cause hair shedding in up to 20% of patients, potentially due to multiple factors including inflammation and psychological stress.

In this retrospective study, 88.2% of women with female-pattern hair loss who underwent hair transplantation reported more than 75% satisfaction, with higher satisfaction noted in those receiving the most implants; however, complications such as pain and scarring were also observed.

This study suggested that differences in hair follicle development, indicated by the frequency of underdeveloped hairs, significantly contribute to the variation in hair loss severity among Japanese individuals with the LIPH c.736T>A mutation.

Propranolol can cause reversible hair loss.

This study reports that horizontal sections of scalp biopsies improve the diagnosis of alopecia areata, especially when characteristic inflammatory infiltrates are missing.

This review discusses a clinical approach to diagnosing alopecia through patient history and clinical findings, but it reports no new clinical results.

Red and infrared light therapy improves hair growth in balding patients.

This study found that photoepilation using intense pulsed light significantly reduced hair growth parameters, and phototrichograms may offer an objective method to evaluate its effectiveness.

This article examines various types of childhood alopecia and highlights the importance of identifying chronic conditions or those linked to underlying medical issues, but reports no new results.

This article discusses the use of imiquimod as a treatment for actinic keratosis, basal cell carcinoma, and human papillomavirus warts, noting both its therapeutic benefits and common side effects such as local inflammation and flu-like symptoms.

This case study presents an asthma patient with H1N1 pneumonia who developed invasive Aspergillosis despite avoiding steroids, suggesting that factors other than steroid use can contribute to IA in such patients.

This review discusses the causes and treatments of hair loss in women, such as telogen effluvium and female pattern hair loss, and provides no new research results.

In this study on Swiss albino mice, researchers reported that perilla leaf extract stimulated hair growth similarly to minoxidil, counteracting hair loss induced by testosterone injections.

This article discusses the diagnosis and management of iron deficiency without anemia, but reports no new results; comments on dermatological aspects are also included.

This study found that a hair tonic containing 1% teak leaf extract significantly increased hair growth and user satisfaction in men with androgenic alopecia after 24 weeks, without causing adverse effects, and was comparable to the standard treatment, minoxidil.

This review discusses treatment options for various types of alopecia in children and reports no new clinical results; it analyzes the existing literature on safety and efficacy.

This chapter reviews the prevalence, pathogenesis, and management of hair and scalp disorders but reports no new clinical findings.

This study assessed the psychosocial impact and disease burden of alopecia areata among adolescents and adults in Australia, finding substantial impacts on physical, emotional, and quality of life overall, with greater disease burden in patients experiencing more extensive hair loss.

This study found that Iranian patients with androgenetic alopecia had a higher terminal to vellus hair ratio compared to previous studies in Whites, suggesting potential onset of miniaturization.

This abstract provides no new data or findings as it is a placeholder text rather than a research summary.

This case report describes a patient with eosinophilia-myalgia syndrome who experienced severe, persistent telogen effluvium.

This study found no protective effect of topical calcipotriol on hair loss in chemotherapy patients, and the authors propose the term "atrophic telogen effluvium" for this type of hair loss.

Finasteride 1mg helps reverse hair miniaturization in men and postmenopausal women.

This study found no significant link between iron metabolism, including serum ferritin and hemoglobin levels, and telogen effluvium in women under 40 years old.

This study found that a new hair loss lotion containing various cosmetic ingredients significantly increased total hair fibers and anagen hairs in individuals with androgenetic alopecia and telogen effluvium, while also improving visual hair characteristics and receiving positive user feedback without adverse effects.

This article describes acute and chronic telogen effluvium, highlighting the importance of differentiating them from androgenetic alopecia for accurate diagnosis and treatment strategies but includes no new clinical research findings.